Glutamate release and neuronal damage in ischemia

Area of Science:

• Neuroscience
• Cerebrovascular Biology
• Neuroprotection

Background:

• Ischemic stroke causes neuronal injury mediated by excessive glutamate receptor activation.
• Elevated extracellular glutamate in the ischemic brain results from enhanced release and reduced uptake.
• Glutamate efflux mechanisms include calcium-dependent early release and calcium-independent late release via transporters.

Purpose of the Study:

• To investigate the mechanisms of extracellular glutamate elevation during ischemia.
• To establish the direct link between enhanced glutamate release and neuronal injury.
• To explore neuroprotective strategies targeting glutamate receptors.

Main Methods:

• Analysis of extracellular glutamate levels in the ischemic brain.
• Investigation of glutamate transporter function and calcium channel involvement.
• Experimental models using cultured neurons exposed to ischemic conditions and glutamate receptor agonists.
• Assessment of neuroprotection by NMDA receptor antagonists.

Main Results:

• Ischemia rapidly elevates extracellular glutamate through both enhanced efflux and reduced uptake.
• Early glutamate efflux is calcium-dependent, while later efflux is calcium-independent, mediated by reversed glutamate transporters.
• While high extracellular glutamate is observed, it doesn't solely cause neuronal loss in cultured neurons.
• NMDA receptor antagonists administered after glutamate receptor agonist exposure rescue cultured neurons.

Conclusions:

• Late NMDA receptor blockade can provide neuroprotection.
• Neuroprotection may occur via blocking presynaptic glutamate release or postsynaptic NMDA receptor sensitization.
• Understanding glutamate excitotoxicity mechanisms is crucial for developing stroke therapies.